Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk
Agnieszka Dejda, … , Nathalie Labrecque, Przemyslaw Sapieha
Agnieszka Dejda, … , Nathalie Labrecque, Przemyslaw Sapieha
Published October 1, 2014
Citation Information: J Clin Invest. 2014;124(11):4807-4822. https://doi.org/10.1172/JCI76492.
View: Text | PDF
Research Article Immunology

Neuropilin-1 mediates myeloid cell chemoattraction and influences retinal neuroimmune crosstalk

  • Text
  • PDF
Abstract

Immunological activity in the CNS is largely dependent on an innate immune response and is heightened in diseases, such as diabetic retinopathy, multiple sclerosis, amyotrophic lateral sclerosis, and Alzheimer’s disease. The molecular dynamics governing immune cell recruitment to sites of injury and disease in the CNS during sterile inflammation remain poorly defined. Here, we identified a subset of mononuclear phagocytes (MPs) that responds to local chemotactic cues that are conserved among central neurons, vessels, and immune cells. Patients suffering from late-stage proliferative diabetic retinopathy (PDR) had elevated vitreous semaphorin 3A (SEMA3A). Using a murine model, we found that SEMA3A acts as a potent attractant for neuropilin-1–positive (NRP-1–positive) MPs. These proangiogenic MPs were selectively recruited to sites of pathological neovascularization in response to locally produced SEMA3A as well as VEGF. NRP-1–positive MPs were essential for disease progression, as NRP-1–deficient MPs failed to enter the retina in a murine model of oxygen-induced retinopathy (OIR), a proxy for PDR. OIR mice with NRP-1–deficient MPs exhibited decreased vascular degeneration and diminished pathological preretinal neovascularization. Intravitreal administration of a NRP-1–derived trap effectively mimicked the therapeutic benefits observed in mice lacking NRP-1–expressing MPs. Our findings indicate that NRP-1 is an obligate receptor for MP chemotaxis, bridging neural ischemia to an innate immune response in neovascular retinal disease.

Authors

Agnieszka Dejda, Gaelle Mawambo, Agustin Cerani, Khalil Miloudi, Zhuo Shao, Jean-Francois Daudelin, Salix Boulet, Malika Oubaha, Felix Beaudoin, Naoufal Akla, Sullivan Henriques, Catherine Menard, Andreas Stahl, Jean-Sébastien Delisle, Flavio A. Rezende, Nathalie Labrecque, Przemyslaw Sapieha

×

Figure 5

The NRP-1 ligand SEMA3A is induced in patients suffering from PDR.

Options: View larger image (or click on image) Download as PowerPoint
The NRP-1 ligand SEMA3A is induced in patients suffering from PDR.
Angio...
Angiographies, funduscopies, spectral-domain optical coherence tomography (SD-OCT), and 3D retinal maps obtained from patients selected for the study. Control patients had nonvascular pathologies and were compared with patients with PDR. Control patients with epiretinal membrane shows signs of non-diabetes–related retinal damage, such as (A and B) tractional tension on vasculature (arrow) secondary to (C) fibrotic tissue (white arrow) and macular bulging (angiography and 3D map). Retinas from patients with PDR have (E) neovascularization (high-magnification image) with (D) highly permeable microvessels, as evidenced by leakage of fluorescent dye (high-magnification image), (F) microaneurysms (arrows in high-magnification image), and (G) fibrous scar tissue (arrow), indicative of advanced retinopathy. (H) Patients with PDR show some evidence of macular edema, including cystoid formation (white arrowhead) due to focal coalescence of extravasated fluid. (I) Vitreous humor analyzed by ELISA shows 5-fold increased levels of SEMA3A protein in patients with PDR. Horizontal bars represent mean concentration of SEMA3A, and dots represent concentrations of individual samples; n = 17 for controls and 17 for patients with PDR; *P < 0.05. (J) Western blot analysis of equal volumes of vitreous corroborates the increase in SEMA3A (~125 KDa and 95 KDa) in patients with PDR with respect to controls. Scale bars: 1,500 μm (A–G); 300 μm (C and H).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts